To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb to discuss COVID vaccines, antibodies, and FDA considerations. Dr. Gottlieb is reasonably confident that one or more COVID vaccines will be successful. He believes the Phase 1 and 2 data published thus far has demonstrated relatively robust immunogenicity and also the…
The table has turned. In 2022, the S&P 500 (SPX) and peer indices finished the first half of the...
9 key macro events this week, but Treasury refunding most important arguably. Incoming data likely soft-ish which should help...
“An investor’s job is not to avoid the pain but to endure it.” If you would like to...
With defensive stocks now expensive and offering little absolute upside, the S&P500 appears ready to join the ongoing bear...
That was the longest, short trading week I’ve ever experienced (Seth Golden taking the helm of this week’s reporting,...
Many believe that bond yields will not be able to move up much, partly as there is no sustained...
“Keep It Simple Stunad for 2023: Market will be well beyond your comfort-BUY level by the time your defined...
The S&P 500 (SPX) has surpassed its previous high among a global pandemic and an uncertain economy. The index...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
